Sample6
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$5.8m | Series A | ||
$11.0m | Series B | ||
$6.5m | Series B | ||
$2.5m | Series B | ||
$12.7m | Series C | ||
Total Funding | AUD59.5m |
Related Content
Recent News about Sample6
EditSample6 is a biotechnology company specializing in pathogen detection systems for laboratories. The company operates in the healthcare and food safety markets, providing solutions that streamline the detection of harmful pathogens. Sample6's core product, the DETECT HT system, features intuitive software and a scalable design, allowing laboratories to process up to 1,000 samples in just three hours. The system is designed for ease of use, with a single transfer sponge bag to assay plate option that simplifies operations. Sample6 serves laboratories that require efficient and reliable pathogen detection, including those in the healthcare, food safety, and environmental sectors. The business model is based on selling its detection systems and related consumables, generating revenue through both initial sales and recurring purchases of assay kits. The company aims to maximize laboratory efficiency while minimizing resource usage, making it a cost-effective solution for its clients.
Keywords: pathogen detection, biotechnology, healthcare, food safety, laboratory efficiency, scalable design, intuitive software, high throughput, assay kits, cost-effective.